Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer
Everett J. Moding(Stanford Medicine), Maximilian Diehn(Stanford University), Billy W. Loo(Princess Margaret Cancer Centre), Kavitha Ramchandran(Stanford University), Barzin Y. Nabet(Gene Therapy Laboratory), Jianzhong He(The University of Texas MD Anderson Cancer Center), Yufei Liu(The University of Texas MD Anderson Cancer Center), Joel W. Neal(Stanford Medicine), Heather A. Wakelee(Palo Alto Institute), Rene F. Bonilla(Stanford University), John V. Heymach(The University of Texas MD Anderson Cancer Center), Christopher H. Yoo(Stanford University), Ryan B. Ko(Stanford University), Sukhmani K. Padda(Stanford University), Millie Das(VA Palo Alto Health Care System), Daniel R. Gomez(Cedars-Sinai Medical Center), Angela B. Hui(Stanford University), Anne S. Tsao(The University of Texas MD Anderson Cancer Center), Linda Gojenola(Stanford University), Aadel A. Chaudhuri(Washington University in St. Louis), Jacob J. Chabon(Foresight Science & Technology (United States)), Steven H. Lin(The University of Texas MD Anderson Cancer Center), Ting Xu(The University of Texas MD Anderson Cancer Center), Zhongxing Liao(Thoracic Surgery Foundation), Carol D. Jones(Stanford University), Yawei Qiao(The University of Texas MD Anderson Cancer Center), Ash A. Alizadeh(California Institute for Regenerative Medicine)
Cited by 369
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
|The Lancet|2021|1.5k
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
|Journal of Clinical Oncology|2019|1.3k
Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia
|The Journal of Experimental Medicine|2001|1.1k